List of Tables
Table 1. Global Neutropenia Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Injection
Table 4. Global Neutropenia Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Neutropenia Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Neutropenia Drugs Sales by Region (2017-2022) & (K MT)
Table 7. Global Neutropenia Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Neutropenia Drugs Sales by Region (2023-2028) & (K MT)
Table 9. Global Neutropenia Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Neutropenia Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Neutropenia Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Neutropenia Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Neutropenia Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Neutropenia Drugs Sales by Manufacturers (2017-2022) & (K MT)
Table 15. Global Neutropenia Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Neutropenia Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Neutropenia Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Neutropenia Drugs Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Neutropenia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Neutropenia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neutropenia Drugs as of 2021)
Table 21. Neutropenia Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Neutropenia Drugs Product Offered
Table 23. Date of Manufacturers Enter into Neutropenia Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
Table 26. Global Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
Table 27. Global Neutropenia Drugs Sales Share by Type (2017-2022)
Table 28. Global Neutropenia Drugs Sales Share by Type (2023-2028)
Table 29. Global Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Neutropenia Drugs Revenue Share by Type (2017-2022)
Table 32. Global Neutropenia Drugs Revenue Share by Type (2023-2028)
Table 33. Neutropenia Drugs Price by Type (2017-2022) & (USD/MT)
Table 34. Global Neutropenia Drugs Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
Table 36. Global Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
Table 37. Global Neutropenia Drugs Sales Share by Application (2017-2022)
Table 38. Global Neutropenia Drugs Sales Share by Application (2023-2028)
Table 39. Global Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Neutropenia Drugs Revenue Share by Application (2017-2022)
Table 42. Global Neutropenia Drugs Revenue Share by Application (2023-2028)
Table 43. Neutropenia Drugs Price by Application (2017-2022) & (USD/MT)
Table 44. Global Neutropenia Drugs Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
Table 46. North America Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
Table 47. North America Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
Table 50. North America Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
Table 51. North America Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Neutropenia Drugs Sales by Country (2017-2022) & (K MT)
Table 54. North America Neutropenia Drugs Sales by Country (2023-2028) & (K MT)
Table 55. North America Neutropenia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Neutropenia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
Table 58. Europe Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
Table 59. Europe Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
Table 62. Europe Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
Table 63. Europe Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Neutropenia Drugs Sales by Country (2017-2022) & (K MT)
Table 66. Europe Neutropenia Drugs Sales by Country (2023-2028) & (K MT)
Table 67. Europe Neutropenia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Neutropenia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
Table 70. Asia Pacific Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
Table 71. Asia Pacific Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
Table 74. Asia Pacific Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
Table 75. Asia Pacific Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Neutropenia Drugs Sales by Region (2017-2022) & (K MT)
Table 78. Asia Pacific Neutropenia Drugs Sales by Region (2023-2028) & (K MT)
Table 79. Asia Pacific Neutropenia Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Neutropenia Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
Table 82. Latin America Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
Table 83. Latin America Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
Table 86. Latin America Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
Table 87. Latin America Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Neutropenia Drugs Sales by Country (2017-2022) & (K MT)
Table 90. Latin America Neutropenia Drugs Sales by Country (2023-2028) & (K MT)
Table 91. Latin America Neutropenia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Neutropenia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
Table 94. Middle East and Africa Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
Table 95. Middle East and Africa Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
Table 98. Middle East and Africa Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
Table 99. Middle East and Africa Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Neutropenia Drugs Sales by Country (2017-2022) & (K MT)
Table 102. Middle East and Africa Neutropenia Drugs Sales by Country (2023-2028) & (K MT)
Table 103. Middle East and Africa Neutropenia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Neutropenia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. Apotex Inc. Corporation Information
Table 106. Apotex Inc. Description and Major Businesses
Table 107. Apotex Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. Apotex Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Apotex Inc. Recent Developments
Table 110. Biogenomics Limited Corporation Information
Table 111. Biogenomics Limited Description and Major Businesses
Table 112. Biogenomics Limited Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Biogenomics Limited Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Biogenomics Limited Recent Developments
Table 115. Cellerant Therapeutics, Inc. Corporation Information
Table 116. Cellerant Therapeutics, Inc. Description and Major Businesses
Table 117. Cellerant Therapeutics, Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Cellerant Therapeutics, Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Cellerant Therapeutics, Inc. Recent Developments
Table 120. Coherus BioSciences, Inc. Corporation Information
Table 121. Coherus BioSciences, Inc. Description and Major Businesses
Table 122. Coherus BioSciences, Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Coherus BioSciences, Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Coherus BioSciences, Inc. Recent Developments
Table 125. Dr. Reddy’s Laboratories Limited Corporation Information
Table 126. Dr. Reddy’s Laboratories Limited Description and Major Businesses
Table 127. Dr. Reddy’s Laboratories Limited Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. Dr. Reddy’s Laboratories Limited Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Dr. Reddy’s Laboratories Limited Recent Developments
Table 130. Ligand Pharmaceuticals, Inc. Corporation Information
Table 131. Ligand Pharmaceuticals, Inc. Description and Major Businesses
Table 132. Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. Ligand Pharmaceuticals, Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Ligand Pharmaceuticals, Inc. Recent Developments
Table 135. NAL Pharmaceuticals Ltd. Corporation Information
Table 136. NAL Pharmaceuticals Ltd. Description and Major Businesses
Table 137. NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. NAL Pharmaceuticals Ltd. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. NAL Pharmaceuticals Ltd. Recent Developments
Table 140. Prolong Pharmaceuticals, LLC Corporation Information
Table 141. Prolong Pharmaceuticals, LLC Description and Major Businesses
Table 142. Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. Prolong Pharmaceuticals, LLC Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Prolong Pharmaceuticals, LLC Recent Developments
Table 145. Richter Gedeon Nyrt. Corporation Information
Table 146. Richter Gedeon Nyrt. Description and Major Businesses
Table 147. Richter Gedeon Nyrt. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 148. Richter Gedeon Nyrt. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Richter Gedeon Nyrt. Recent Developments
Table 150. Sandoz International GmbH Corporation Information
Table 151. Sandoz International GmbH Description and Major Businesses
Table 152. Sandoz International GmbH Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 153. Sandoz International GmbH Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Sandoz International GmbH Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Neutropenia Drugs Distributors List
Table 158. Neutropenia Drugs Customers List
Table 159. Neutropenia Drugs Market Trends
Table 160. Neutropenia Drugs Market Drivers
Table 161. Neutropenia Drugs Market Challenges
Table 162. Neutropenia Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Neutropenia Drugs Product Picture
Figure 3. Global Neutropenia Drugs Market Share by Type in 2021 & 2028
Figure 3. Capsule Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Neutropenia Drugs Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Neutropenia Drugs Report Years Considered
Figure 9. Global Neutropenia Drugs Sales 2017-2028 (K MT)
Figure 10. Global Neutropenia Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Neutropenia Drugs Revenue 2017-2028 (US$ Million)
Figure 12. Global Neutropenia Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Neutropenia Drugs Sales Market Share by Region (2017-2022)
Figure 14. Global Neutropenia Drugs Sales Market Share by Region (2023-2028)
Figure 15. North America Neutropenia Drugs Sales YoY (2017-2028) & (K MT)
Figure 16. North America Neutropenia Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Neutropenia Drugs Sales YoY (2017-2028) & (K MT)
Figure 18. Europe Neutropenia Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Neutropenia Drugs Sales YoY (2017-2028) & (K MT)
Figure 20. Asia-Pacific Neutropenia Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Neutropenia Drugs Sales YoY (2017-2028) & (K MT)
Figure 22. Latin America Neutropenia Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Neutropenia Drugs Sales YoY (2017-2028) & (K MT)
Figure 24. Middle East & Africa Neutropenia Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Neutropenia Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Neutropenia Drugs in the World: Market Share by Neutropenia Drugs Revenue in 2021
Figure 27. Global Neutropenia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Neutropenia Drugs Sales Market Share by Type (2017-2028)
Figure 29. Global Neutropenia Drugs Revenue Market Share by Type (2017-2028)
Figure 30. Global Neutropenia Drugs Sales Market Share by Application (2017-2028)
Figure 31. Global Neutropenia Drugs Revenue Market Share by Application (2017-2028)
Figure 32. North America Neutropenia Drugs Sales Market Share by Type (2017-2028)
Figure 33. North America Neutropenia Drugs Revenue Market Share by Type (2017-2028)
Figure 34. North America Neutropenia Drugs Sales Market Share by Application (2017-2028)
Figure 35. North America Neutropenia Drugs Revenue Market Share by Application (2017-2028)
Figure 36. North America Neutropenia Drugs Sales Share by Country (2017-2028)
Figure 37. North America Neutropenia Drugs Revenue Share by Country (2017-2028)
Figure 38. U.S. Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Neutropenia Drugs Sales Market Share by Type (2017-2028)
Figure 41. Europe Neutropenia Drugs Revenue Market Share by Type (2017-2028)
Figure 42. Europe Neutropenia Drugs Sales Market Share by Application (2017-2028)
Figure 43. Europe Neutropenia Drugs Revenue Market Share by Application (2017-2028)
Figure 44. Europe Neutropenia Drugs Sales Share by Country (2017-2028)
Figure 45. Europe Neutropenia Drugs Revenue Share by Country (2017-2028)
Figure 46. Germany Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. France Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Neutropenia Drugs Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Neutropenia Drugs Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Neutropenia Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Neutropenia Drugs Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Neutropenia Drugs Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Neutropenia Drugs Revenue Share by Region (2017-2028)
Figure 57. China Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. India Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Neutropenia Drugs Sales Market Share by Type (2017-2028)
Figure 68. Latin America Neutropenia Drugs Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Neutropenia Drugs Sales Market Share by Application (2017-2028)
Figure 70. Latin America Neutropenia Drugs Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Neutropenia Drugs Sales Share by Country (2017-2028)
Figure 72. Latin America Neutropenia Drugs Revenue Share by Country (2017-2028)
Figure 73. Mexico Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Neutropenia Drugs Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Neutropenia Drugs Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Neutropenia Drugs Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Neutropenia Drugs Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Neutropenia Drugs Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Neutropenia Drugs Revenue Share by Country (2017-2028)
Figure 82. Turkey Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. Neutropenia Drugs Value Chain
Figure 86. Neutropenia Drugs Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed